Arrhythmias Following Patent Foramen Ovale Closure: An Unsolved Enigma

Area of Science:

• Cardiology
• Neurology
• Interventional Cardiology

Background:

• Patent foramen ovale (PFO) closure is a key strategy for preventing recurrent stroke in embolic stroke of unknown origin (ESUS).
• Supraventricular arrhythmias, primarily atrial fibrillation, are a recognized complication post-PFO closure.
• Recent studies indicate an increased incidence of these arrhythmias, rising to 21%.

Purpose of the Study:

• To review current data on the incidence of de novo supraventricular arrhythmias after PFO closure.
• To explore the complex pathogenesis, including device effects and inflammatory responses.
• To discuss therapeutic strategies for managing this complication.

Main Methods:

• Literature review of studies on PFO closure and post-procedural arrhythmias.
• Analysis of reported incidence rates and proposed etiological mechanisms.
• Synthesis of current management guidelines and therapeutic options.

Main Results:

• The incidence of new-onset atrial fibrillation post-PFO closure has increased significantly in recent years.
• Potential mechanisms involve direct device impact on atrial tissue and post-procedural inflammation.
• Patient heterogeneity necessitates personalized management strategies.

Conclusions:

• While PFO closure reduces stroke recurrence, managing post-procedural arrhythmias is crucial.
• Understanding the multifactorial pathogenesis is key to developing effective treatments.
• An individualized therapeutic approach is recommended for optimal patient outcomes.